Matthew Metzger

Company: Oxford BioTherapeutics

Job title: Program, Alliance & Business Development Manager

Seminars:

Opportunity to be First-in-Class: Considerations for Collaborations with New Targets 11:40 am

What are the economics of having a new target for others to develop an ADC around? Discussing opportunities to be first-in-class pursuing underexploited targets  Debating the decision to leverage the best linker-payload platform or off-patent technologies, considering the influence on the side effect profileRead more

day: Conference Day Two

ADC Deal-Making: Will Success Lead to More Success? 2:45 pm

Discussing opportunity for and examples of creative deal structures across ADCs  For payloads: Do you need the full ADC payload for a deal? For linkers: What drives deals with different types of linkers?  For target discovery: What are the differences in deal structure versus linkers and payloads? Sharing guidance to progress from a research collaboration…Read more

day: Conference Day Two